GlycoMimetics, Inc. (Nasdaq: GLYC) announced that the peer-reviewed journal, Science Translational Medicine, has published preclinical research in its May 25 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE